| 000 | 01264 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517071441.0 | ||
| 264 | 0 | _c20161028 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1873-2402 | ||
| 024 | 7 |
_a10.1016/j.biopsych.2015.07.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLu, Hui-Chen | |
| 245 | 0 | 0 |
_aAn Introduction to the Endogenous Cannabinoid System. _h[electronic resource] |
| 260 |
_bBiological psychiatry _cApr 2016 |
||
| 300 |
_a516-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 |
_aArachidonic Acids _xphysiology |
| 650 | 0 | 4 |
_aCannabinoid Receptor Agonists _xadverse effects |
| 650 | 0 | 4 |
_aDronabinol _xadverse effects |
| 650 | 0 | 4 |
_aEndocannabinoids _xphysiology |
| 650 | 0 | 4 |
_aGlycerides _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeuronal Plasticity |
| 650 | 0 | 4 | _aPolyunsaturated Alkamides |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xphysiology |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB2 _xphysiology |
| 650 | 0 | 4 |
_aSchizophrenia _xphysiopathology |
| 700 | 1 | _aMackie, Ken | |
| 773 | 0 |
_tBiological psychiatry _gvol. 79 _gno. 7 _gp. 516-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopsych.2015.07.028 _zAvailable from publisher's website |
| 999 |
_c25570182 _d25570182 |
||